LakeShore Biopharma Warrants
LSBPW
LSBPW was delisted on the 19th of September, 2025.
23 hedge funds and large institutions have $501K invested in LakeShore Biopharma Warrants in 2024 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
12% more capital invested
Capital invested by funds: $447K → $501K (+$54.2K)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
0.03% less ownership
Funds ownership: 5.33% → 5.3% (-0.03%)
8% less funds holding
Funds holding: 25 → 23 (-2)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Clear Street
New York
|
+$181 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$1.12K |
| 2 |
CAC
Cowen and Company
New York
|
-$289 |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$5 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
UBS Group
Zurich,
Switzerland
| – | -$5 | -68 | Closed |
|
LSBPW Hedge Fund Activity: Q2 2024 in Review
23 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in LakeShore Biopharma Warrants (LSBPW) for Q2 2024, worth a combined $501K — up 12% from $447K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of LSBPW and 0 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 1 added.
The largest buyer was Clear Street, adding an estimated $181. The largest seller was Citadel Advisors, exiting entirely with an estimated $1.12K sold.
- 23 institutional investors held LakeShore Biopharma Warrants (LSBPW) as of Q2 2024, down from 25 in Q1 2024.
- Funds reported $501K of LakeShore Biopharma Warrants stock for Q2 2024, up 12% quarter-over-quarter.
- 0 funds opened new LakeShore Biopharma Warrants positions in Q2 2024 and 2 closed out, a net change of -2 holders.
- The largest LakeShore Biopharma Warrants buyer in Q2 2024 was Clear Street, an estimated $181 added.
- The largest LakeShore Biopharma Warrants seller in Q2 2024 was Citadel Advisors, an estimated $1.12K sold.
Based on aggregated 13F filings for Q2 2024.